T1 Procedure · ESSO Hannover Fellowship · Peritoneal Surface Malignancy

Cytoreductive Surgery (CRS) — Peritoneal Cancer Cytoreductive Surgery (CRS) — Peritoneal Cancer

CRS peritoneal surface malignancy treatment కి foundation. Hannover fellowship లో Prof. Beate Rau దగ్గర ఈ procedure specifically నేర్చుకున్నాను. HIPEC తో combine చేయడం most cases లో. CRS is the foundation of peritoneal surface malignancy treatment. I learned this procedure specifically under Prof. Beate Rau at my Hannover fellowship. It is combined with HIPEC in most cases.

What CRS involves

CRS అంటే ఏమిటిWhat CRS involves

Peritoneum కి cancer spread అయినప్పుడు, tumour deposits multiple sites లో ఉంటాయి. Abdominal organs surface పైన, omentum, mesentery, diaphragm, pelvic structures. CRS goal: ఈ visible deposits అన్నీ surgically remove చేసి "complete cytoreduction" achieve చేయడం. Residual disease ideally 0mm.

Complete cytoreduction achieve చేయడానికి multi-organ involvement common. Small bowel, colon, spleen, gallbladder, uterus, ovaries, peritoneal strips, omentum, diaphragm peritoneum — అవసరమైనవి remove చేయవలసి రావచ్చు. 6-12+ hours typically. Specialised training, experienced anaesthesia, ICU support అవసరం.

PCI (Peritoneal Carcinomatosis Index) 0-39 scale పైన score చేస్తాను. Score 20 కంటే తక్కువ cases లో complete cytoreduction achieve చేయడం, మంచి outcomes రావడం more likely. ఇది patient selection కి critical tool. Prof. Rau దగ్గర ఈ assessment specifically నేర్చుకున్నాను.

When cancer spreads to the peritoneum, tumour deposits are present at multiple sites: on the surface of abdominal organs, the omentum, mesentery, diaphragm and pelvic structures. The goal of CRS is to surgically remove all these visible deposits and achieve "complete cytoreduction" — ideally zero millimetres of residual disease.

Achieving complete cytoreduction often involves multiple organs. Small bowel, colon, spleen, gallbladder, uterus, ovaries, peritoneal strips, omentum and diaphragm peritoneum may all need to be removed. Typically 6-12+ hours. Specialised training, experienced anaesthesia and ICU support are all essential.

I score each case on the PCI (Peritoneal Carcinomatosis Index) scale of 0-39. Cases with a score below 20 are more likely to achieve complete cytoreduction with good outcomes. This is a critical patient selection tool that I learned specifically under Prof. Rau.

Indications

CRS ఎవరికిWho needs CRS

🩻

Peritoneal Mesothelioma

CRS+HIPEC is the standard. Best outcomes of all peritoneal surface malignancies.

🩻

Pseudomyxoma Peritonei

Appendix-origin mucinous tumour. CRS+HIPEC is potentially curative using the Sugarbaker technique.

🩻

Colorectal Peritoneal Metastases

Selected cases with PCI below 20. PRODIGE 7 trial evidence.

🩻

Ovarian Cancer Debulking

Interval debulking with HIPEC. OVHIPEC trial (NEJM 2018).

🩻

Gastric Peritoneal Metastases

Carefully selected cases. Tumor Board evaluation mandatory.

⚖️

Who is not suitable

PCI above 20, distant non-peritoneal metastases, poor performance status. I tell patients honestly when surgery is not the right option.

FAQ

Frequently Asked Questionsతరచుగా అడిగే Questions

Consultation Request Request a Consultation

PDF, JPG, PNG · max 10MB per file · max 3 files PDF, JPG, PNG · max 10MB per file · max 3 files

Submit చేయడం ద్వారా, Dr. Imaduddin team follow-up కోసం మిమ్మల్ని contact చేయడానికి consent ఇస్తున్నారు. Privacy Policy చూడండి. By submitting, you consent to Dr. Imaduddin's team contacting you for follow-up. See our Privacy Policy.

Peritoneal cancer case నాకు చూపించండిShow me your peritoneal cancer case